A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS
暂无分享,去创建一个
G. Comi | M. Rovaris | M. Filippi | G. Comi | A. Ghezzi | V. Martinelli | A. Ceccarelli | E. Judica | M. Filippi | M. Rovaris | A. Ghezzi | V. Martinelli | E. Judica | A. Ceccarelli
[1] M. Filippi,et al. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes , 2005, The Lancet Neurology.
[2] M Cercignani,et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis , 2001, Neurology.
[3] A J Thompson,et al. Gray and white matter volume changes in early RRMS , 2005, Neurology.
[4] O. Ciccarelli,et al. Diffusion MRI in multiple sclerosis , 2005, Neurology.
[5] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[6] R. Ordidge,et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis , 2003, Journal of Neurology.
[7] M. Rovaris,et al. A new method for analyzing histograms of brain magnetization transfer ratios: comparison with existing techniques. , 2004, AJNR. American journal of neuroradiology.
[8] A. Thompson,et al. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis , 2005, The Lancet Neurology.
[9] C. Poser,et al. Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.
[10] Marco Rovaris,et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images , 1997, Journal of Neurology.
[11] Alan J Thompson,et al. The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM‐based segmentation methodology , 2002, Journal of magnetic resonance imaging : JMRI.
[12] Massimo Filippi,et al. Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management , 2005, The Lancet Neurology.
[13] J. Udupa,et al. Magnetization transfer histogram analysis of monosymptomatic episodes of neurologic dysfunction: preliminary findings. , 2000, AJNR. American journal of neuroradiology.
[14] Rohit Bakshi,et al. Gray matter involvement in multiple sclerosis , 2007, Neurology.
[15] A. J. Thompson,et al. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis , 2003, Journal of Neurology.
[16] G. Barker,et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS , 2002, Neurology.
[17] A. Thompson,et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.
[18] S. Reingold,et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.
[19] P. Matthews,et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.
[20] Mike P. Wattjes,et al. Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T , 2006, European Radiology.
[21] Massimo Filippi,et al. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. , 2002, AJNR. American journal of neuroradiology.
[22] G. Comi,et al. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. , 2000, AJNR. American journal of neuroradiology.
[23] Marco Rovaris,et al. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI , 2005, NeuroImage.
[24] M Cercignani,et al. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[25] Marco Rovaris,et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. , 2002, Archives of neurology.
[26] Gareth J. Barker,et al. Diffusion tensor imaging of post mortem multiple sclerosis brain , 2007, NeuroImage.
[27] Chiara Romualdi,et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset , 2007, Journal of Neurology.
[28] À. Rovira,et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes , 2006, Neurology.
[29] Marco Rovaris,et al. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. , 2005, Archives of neurology.
[30] David H. Miller,et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.
[31] D L Hill,et al. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. , 1997, Medical physics.
[32] F. Barkhof,et al. Altered diffusion tensor in multiple sclerosis normal‐appearing brain tissue: Cortical diffusion changes seem related to clinical deterioration , 2006, Journal of magnetic resonance imaging : JMRI.
[33] Carlo Pozzilli,et al. A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. , 2002, Magnetic resonance imaging.
[34] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[35] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[36] A. Thompson,et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[37] Aileen B. Sedman,et al. A longitudinal study , 1987 .
[38] M Rovaris,et al. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. , 2006, Brain : a journal of neurology.
[39] Marco Rovaris,et al. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. , 2005, Archives of neurology.
[40] P Kapeller,et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[41] Frederik Barkhof,et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.